Form4insider filings, from the source

SEC Form 5 · accession 0001209191-16-098119

Kite Pharma, Inc. · KITE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Arie Belldegrun
Officer — Chairman, President and CEO · Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 12, 2016 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Oct 7, 2015G1,240,000$0.00D898,324ISee Footnote
Common StockF2Dec 10, 2015G398,324$0.00D500,000ISee Footnote
Common StockF3Dec 10, 2015G60,000$0.00D2,215,472ISee Footnote
Common StockF3Dec 21, 2015G541,722$0.00D1,673,750ISee Footnote
Common Stockholding———28,200D
Common StockF4holding———159,329ISee Footnote
Common StockF5holding———430,190ISee Footnote
Common StockF6holding———500,000ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses